|
|
|
26.03.26 - 07:30
|
Trump, Xi to Meet in Beijing on May 14–15 | The China Show 3/26/2026 (Bloomberg)
|
|
|
“Bloomberg: The China Show” is your definitive source for news and analysis on the world's second-biggest economy. From politics and policy to tech and trends, Annabelle Droulers and Yvonne Man give global investors unique insight, delivering in-depth discussions with the newsmakers who matter. (Source: Bloomberg)...
|
|
|
|
|
|
|
26.03.26 - 07:01
|
China‑UK Business Council Chief on China Ties (Bloomberg)
|
|
|
Peter Burnett, chief executive of the China‑Britain Business Council, says the UK remains open to investment from China. He spoke with Stephen Engle on Bloomberg's Insight with Haslinda Amin. (Source: Bloomberg)...
|
|
|
|
|
26.03.26 - 06:36
|
Neues Werk eröffnet: BASF will in China aufholen (Cash)
|
|
|
- Der deutsche Chemie-Konzern BASF hat nach fast sechs Jahren Bauzeit und einer Milliardeninvestition seinen neuen Verbundstandort in Südchina eröffnet. In einer Welt, die immer geteilter werde, zeige der Standort Zhanjiang, dass globale Kooperation die besten Ergebnisse erziele, sagte BASF-Vorstand Markus Kamieth in seiner Eröffnungsrede vor chinesischen Regierungsbeamten und BASF-Kunden....
|
|
|
26.03.26 - 06:30
|
China′s Kuaishou slumps as analysts flag growth pressure despite strong results (SCMP)
|
|
|
Shares of Chinese short-video platform Kuaishou fell more than 13 per cent to HK$45.96 by midday in Hong Kong on Thursday, a day after reporting strong sales growth, as analysts warned that its core advertising and live-streaming businesses could face mounting pressure this year.
The sharp decline reflected investor concerns over a cautious growth outlook for the Beijing-based firm, compounded by its heavy spending on artificial intelligence, according to Zhang Xueru, an analyst at investment......
|
|
|
|
|
|
|
|
|
26.03.26 - 05:42
|
Baozun: Gap Plans to Open 50 Stores in China This Year (Bloomberg)
|
|
|
Baozun, the operator of Gap's Greater China business, says it expects the US brand's growth in the mainland to accelerate. Baozun chairman and founder Vincent Qiu also tells “Bloomberg: The China Show” that Gap is preparing for a Hong Kong comeback. (Source: Bloomberg)...
|
|
|
26.03.26 - 05:42
|
Roland Berger′s Depoux: China Is a Beacon of Stability (Bloomberg)
|
|
|
Denis Depoux, Global Managing Director at Roland Berger, says China is emerging as a beacon of stability at a time of heightened global uncertainty. He adds that Beijing's charm offensive appears to be gaining traction, with Europe and Canada increasingly looking to partner with China. He speaks with Bloomberg's Stephen Engle at the annual Boao Forum for Asia in Hainan. (Source: Bloomberg)...
|
|
|
|
|
|
|
26.03.26 - 05:06
|
China′s Jiangsu Aidea eyes Hong Kong listing as gateway to US and European Aids markets (SCMP)
|
|
|
Jiangsu Aidea Pharmaceutical, which develops anti-HIV and Aids treatments, plans to tap Hong Kong's initial public offering (IPO) market as it sets its sights on expansion into the US and Europe in the coming years, an executive said.
The company, listed on the Shanghai Stock Exchange's Star Market, described Hong Kong as a “good window” for going global, citing the city's “flexible” fundraising environment.
Many Chinese corporations – including those in the pharmaceutical sector – would......
|
|
|
|
|
|
|
26.03.26 - 04:06
|
China′s weight-loss drug makers take on global giants as Novo Nordisk patent expires (SCMP)
|
|
|
At least 10 weight-loss injections and oral pills are lining up for regulatory approval in China, in a market projected to reach about US$14 billion by 2030.
Novo Nordisk's blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals.
The rush comes as China's drug regulator accelerates approvals of innovative therapies, helped by a surge in out-licensing deals with global pharmaceutical......
|
|
|
|
|
26.03.26 - 03:36
|
Euro, Chinese yuan to end US dollar dominance, top economist says (SCMP)
|
|
|
Professor Kenneth Rogoff of Harvard University has repeatedly warned that the US dollar is approaching a crisis of legitimacy. Having written extensively on the global recession in the late 2000s, Rogoff has turned his focus to the US currency's increasingly unstable place at the top of the world's financial hierarchy. A former chief economist at the International Monetary Fund and a chess grandmaster, he published Our Dollar, Your Problem in May last year.
In this interview, Rogoff elaborates......
|
|